
- BioPharm International-10-15-2016
- Volume 2016 eBook
- Issue 2
Investigation Effectiveness Drives Human Performance Excellence
Are investigations supporting or hindering performance excellence?
Every biopharm company conducts investigations for undesirable outcomes related to safety, quality, and reliability of product and processes. The question is to what degree do these investigations support or hinder performance excellence? A sub-team that was formed as part of the BioPhorum Operations Group (BPOG) human performance workstream sought to answer this question. The findings suggest that biopharm is behind other industries with respect to investigation best practices. This article provides a pathway for the industry to improve its investigations, and in so doing, improve overall organizational learning and performance.
Download the BioPharm International
.
Articles in this issue
almost 9 years ago
Cell Line Quality Technologiesalmost 9 years ago
Data Integrity Challenges in Manufacturingalmost 9 years ago
Evaluating Technology and Innovation in Biopharmaceutical Manufacturingalmost 9 years ago
Seeking Accelerated Biosimilar Characterizationalmost 9 years ago
Plant-Made Pharmaceuticals—Accelerating Drug Development Globallyalmost 9 years ago
Testing the BrothNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.